From Sizable Stake Zero: Why Agios Backer Vanished
When a big investor exits a biotech stock, it rattles the market and raises questions. This deep dive explains the 'f...
Take advantage of free courses on financial planning for beginners to boost your financial knowledge. Start your learning journey today.
11,577 articlesWhen a big investor exits a biotech stock, it rattles the market and raises questions. This deep dive explains the 'f...
As market conditions shift in 2026, five very safe high-yield dividend stocks stand out for lifelong ownership, backe...
When a major investor exits a growing SaaS company, the move can shake confidence and the stock. This article examine...
Berkshire Hathaway’s long-running bets on Coca-Cola and American Express continue to pay off in 2025. This article br...
Russia’s accusation that the United States carried out a ‘pre-planned’ strike against Iran jolts global markets as oi...
Start your week with a proven investing ritual. This guide delivers 10 Monday reads—practical, data-driven, and ready...
As retirement nears, the choice between Original Medicare and Medicare Advantage becomes personal. This piece shares ...
A prominent fund disclosed a sizable exit from its Ether ETF stake, selling millions worth of ETHA shares while leavi...
A major investor sold a substantial stake in an Ethereum ETF, pulling out nearly $19 million in one trade. The move r...
A practical guide to interpreting Champions Oncology earnings. We break down the numbers, trends, and what to watch n...
Kinsale Capital has faced headwinds, but the core business still shows quality underwriting. Here’s why I’m staying i...
A high-profile move by a Palantir insider is sparking debate about valuations, AI stock exposure, and the road ahead ...